company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3545000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3545000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,34000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,59000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,327000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,109000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3016000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3016000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-130000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3000000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2870000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2870000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-146000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6328000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6328000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,933000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,581000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-399000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5198000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5198000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4500000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-454000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4046000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4046000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1163000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10748000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10748000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,17000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2377000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3549000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,816000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3989000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3989000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,7500000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1258000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6242000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6242000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2242000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10282000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10282000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,17000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,830000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4519000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,34000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4882000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4882000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-35000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-35000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-35000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,71870000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1923000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,69947000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,69947000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,65030000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6671000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6671000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,56000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1922000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,181000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4497000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4497000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-29000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-29345000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-29374000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-29374000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,65000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,65000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,65000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-33806000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 19:00:28+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11814000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11814000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,101000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2382000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,891000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8424000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8424000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-30000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2507000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2985000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,448000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,448000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,9000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7967000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13147000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13147000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,19000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,90000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2392000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1175000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9471000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9471000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-87000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2741000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9175000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6347000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6347000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,124672000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,54000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,124132000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,124132000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,121008000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16501000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16501000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,23000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,246000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2482000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2416000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11334000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11334000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-35000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-60783000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10079000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-50739000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-50739000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1225000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1225000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-63298000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17239000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17239000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,24000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,240000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2741000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,927000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13307000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13307000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-539000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8188000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14828000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6101000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6101000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,35000000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,70000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,35070000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,35070000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,27864000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,551000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 13:38:09+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18786000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18786000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,36000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,220000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3476000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1227000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16281000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16281000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-513000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5787000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9509000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3209000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3209000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,426000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,112000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,538000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,538000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12534000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,539000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q2,2015-04-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,469000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17961000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17961000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,42000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,211000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3316000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2469000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11923000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11923000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-803000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12585000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18475000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5087000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5087000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11674000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1192000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12866000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12866000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6030000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,545000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q3,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,131000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20377000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20377000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,150000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,204000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3412000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2376000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14235000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14235000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1425000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-20312000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16722000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5015000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5015000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3447000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-83000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3364000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3364000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15886000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,551000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22704000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22704000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,223000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,222000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3534000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-633000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19358000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19358000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-335000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-13265000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16036000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2436000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2436000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,252000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-124000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,128000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,128000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16794000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,551000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 17:13:06+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1789000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23219000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23219000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,234000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,204000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3881000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1574000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20474000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20474000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-124000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5963000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8779000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2692000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2692000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1791000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,244000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2035000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2035000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15747000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q2,2016-04-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,545000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23814000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23814000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,245000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,204000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4099000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1896000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21162000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21162000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-933000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-720000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10540000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8887000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8887000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,165344000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,350000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,165694000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,165694000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,153419000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,545000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q3,2016-07-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29322000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29322000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,268000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,198000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5280000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4730000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18846000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18846000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3685000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15221000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22991000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4085000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4085000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1096000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1896000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-32000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,768000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,768000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13993000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,551000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25787000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25787000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,291000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,128000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4850000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4336000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24854000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24854000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-904000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-45561000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12860000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-33605000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-33605000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,48000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,48000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,48000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:42:43+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-58411000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28433000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28433000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,309000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,85000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7030000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,77000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20932000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20932000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1690000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8866000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11941000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1385000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1385000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,122046000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,617000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,122663000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,122663000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,103116000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32372000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32372000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,316000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,69000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6714000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3996000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21277000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21277000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4479000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-46790000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23895000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-27374000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-27374000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,744000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-665000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,79000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,79000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-48572000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-58513000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-58513000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,494000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,33000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,32887000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1051000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26150000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26150000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8897000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-10500000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3273000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,39457000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16787000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16787000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,685000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,12169000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12854000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12854000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3491000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2188000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40699000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40699000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,487000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-22000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8869000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9470000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-40835000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-40835000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9126000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-56195000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23775000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-41546000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-41546000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-239000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,135972000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1420000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,134313000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,134313000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 18:21:56+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,51932000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-55024000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-55024000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,594000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,222000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10003000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7241000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-36964000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-36964000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13906000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,69052000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,55146000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,55146000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-148000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3113000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2965000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2965000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,21147000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-85388000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-85388000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,649000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,633000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,33995000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6848000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-43263000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-43263000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6372000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14470000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8098000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8098000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1769000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2933000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1693000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-529000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-529000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-35694000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-51458000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-51458000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,712000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,813000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9650000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8769000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-31514000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-31514000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1909000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1000000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-909000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-909000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-410000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,697000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,287000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,287000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-32136000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1774000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47951000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47951000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,564000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2105000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11311000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-14668000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-48639000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-48639000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4939000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4939000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4939000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-747000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,375000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-372000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-372000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:03:14+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-53950000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47164000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47164000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1495000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2946000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9540000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3287000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-36470000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-36470000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2179000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2179000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2179000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,112000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-968000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-856000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-856000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-39505000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-49402000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-49402000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1551000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1284000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9197000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-827000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-38197000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-38197000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-793000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-97268000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-98061000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-98061000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-233000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,308349000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-32519000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,275597000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,275597000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,139339000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-55064000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-55064000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1528000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,6641000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,20263000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-492000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27124000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27124000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2047000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7835000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-68186000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-78068000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-78068000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1237000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,684000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,983000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,430000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,430000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-104762000.0
Aerie Pharmaceuticals Inc,AERI,,0001337553,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,6496000.0
